SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-002761
Filing Date
2020-01-09
Accepted
2020-01-09 16:34:17
Documents
2
Period of Report
2020-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1595
2 POA DOCUMENT poa.txt EX-24.3_888111 3922
  Complete submission text file 0001209191-20-002761.txt   6873
Mailing Address C/O VIROPHARMA INC 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
MILANO VINCENT (Reporting) CIK: 0001187159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 20518533

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations